🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this national, prospective, multi-centre observational stu...
Status
Active Not Recruiting
Location
University Hospital of Cologne
Start Date
2021-03-25
Trial ID
NCT04985318
Treatments Being Tested
Primary Objective: To evaluate the effect of caplacizumab on prevention of...
Status
Completed
Location
Investigational Site Number 3920009
Start Date
2019-10-21
Trial ID
NCT04074187
The aim of the study is to evaluate the efficacy of a personalized caplaciz...
Status
Terminated
Location
Chu Amiens
Start Date
2021-04-26
Trial ID
NCT04720261
Treatments Being Tested
The purpose of this multi-country, retrospective data collection study (cha...
Status
Completed
Location
Sanofi-Aventis
Start Date
2022-06-08
Trial ID
NCT05263193
Treatments Being Tested
Primary objective: To assess the safety and tolerability of single ascendi...
Status
Completed
Location
Investigator Site
Start Date
2017-06-05
Trial ID
NCT03172208
The study was a Phase III, double-blind, placebo-controlled, randomized stu...
Status
Completed
Location
Investigator Site
Start Date
2015-11
Trial ID
NCT02553317
Treatments Being Tested
Thrombotic thrombocytopenic purpura (TTP) is a rare disease with a mortalit...
Status
Unknown
Location
FPG
Start Date
2021-10-21
Trial ID
NCT05785468
Treatments Being Tested
This is a multicenter, randomized and open-label Phase II study to compare ...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT01020383
The objectives of this study were to evaluate long-term safety and efficacy...
Status
Completed
Location
Investigator site
Start Date
2016-10-06
Trial ID
NCT02878603
Treatments Being Tested
This is a single group, treatment, Phase 3, open-label, single-arm study to...
Status
Completed
Location
University of Alabama- Site Number : 8400011
Start Date
2022-11-21
Trial ID
NCT05468320
Treatments Being Tested